• IWP-2: Enabling Precision Modulation of Wnt Signaling in Tra

  2026-04-24

  This thought-leadership article explores the mechanistic power and translational impact of IWP-2, a potent Wnt production inhibitor, in dissecting cellular fate and disease mechanisms. Featuring evidence from corneal regenerative research and cancer studies, it offers actionable protocol guidance, contextual product intelligence, and strategic vision for researchers seeking to translate pathway insights into clinical innovation.

• Norovirus Exploits NINJ1 for Selective NS1 Protein Secretion

  2026-04-24

  This study reveals how murine norovirus (MNoV) hijacks the host protein NINJ1 to selectively secrete its NS1 protein through an unconventional, apoptosis-linked pathway. By uncovering the molecular basis for this selectivity, the work advances our understanding of viral immune evasion and cell death regulation.

• LY294002: Applied PI3K/Akt/mTOR Inhibition in Cancer Researc

  2026-04-23

  LY294002, a potent and reversible PI3K/Akt/mTOR pathway inhibitor, is transforming experimental cancer research with its stability, specificity, and versatility. This guide details real-world workflows, protocol tips, and troubleshooting insights that empower researchers to optimize outcomes in apoptosis, autophagy, and tumor immunology studies using LY294002 from APExBIO.

• GSK J4 HCl: Applied JMJD3 Inhibition for Epigenetic Research

  2026-04-23

  GSK J4 HCl empowers researchers to precisely interrogate JMJD3-dependent chromatin regulation, with robust applications in inflammation and tumor modeling. This guide translates breakthrough mechanistic insights and experimental best practices into actionable workflows, maximizing the impact of this selective inhibitor in advanced epigenetic regulation research.

• Direct Reprogramming of Human Fibroblasts into Cardiomyocyte

  2026-04-22

  Romero-Tejeda et al. identify a novel transcription factor combination enabling efficient direct reprogramming of human cardiac fibroblasts to spontaneously contracting cardiomyocyte-like cells. Their use of high-throughput combinatorial screening, with validation of the Wnt/β-catenin pathway's modulatory role, offers new avenues for cardiac regeneration research.

• Crizotinib Hydrochloride: Advanced ALK Kinase Inhibition in

  2026-04-22

  Crizotinib hydrochloride empowers researchers to dissect oncogenic kinase signaling in physiologically relevant, patient-derived assembloid models. This guide offers stepwise workflow enhancements, troubleshooting strategies, and quantitative protocol insights for optimizing ALK and c-Met inhibition in preclinical cancer biology.

• Cdk5 Downregulation Mitigates Neuronal Ferroptosis via AMPK

  2026-04-21

  This study demonstrates that inhibiting Cdk5 activity in ischemic stroke models reverses neuronal ferroptosis by modulating the AMPK pathway and microglial polarization. The findings provide mechanistic insight into neuroprotection strategies targeting iron-dependent cell death and inflammation in the hippocampus.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Control of β-Cate

  2026-04-21

  Explore the advanced mechanistic, assay, and translational insights of the G007-LK tankyrase 1/2 inhibitor in modulating Wnt/β-catenin and Hippo pathways. This article uniquely integrates in-depth evidence, protocol guidance, and recent cross-pathway findings to enhance APC mutation colorectal and hepatocellular cancer research.

• Targeted SPP1 Inhibition in Tumor-Associated Macrophages Red

  2026-04-20

  This study introduces a phenotypic screening approach to identify small molecule modulators that suppress SPP1 expression in tumor-associated macrophages (TAMs), a key driver of tumor progression. The lead compound, delivered via a TAM-avid nanoformulation, achieved robust tumor size reduction in vivo, highlighting a novel therapeutic avenue for targeting TAMs in cancer.

• Lypressin Acetate: Applied Workflows in Vasopressor Assays

  2026-04-20

  Lypressin acetate (lysine vasopressin acetate) stands out for its dual antidiuretic and vasoconstrictive properties, enabling robust experimental modeling of GPCR signaling, vasopressor activity, and emerging antiviral targets. This guide translates recent findings and industry best practices into actionable workflows, protocol parameters, and troubleshooting strategies for researchers optimizing their peptide hormone assays with confidence.

• IGF2BP1-m6A Axis Drives Macrophage Glycolysis in Pulmonary F

  2026-04-19

  This study uncovers a mechanistic axis where the m6A reader IGF2BP1 stabilizes THBS1 mRNA, enhancing macrophage glycolysis and M2 polarization to promote pulmonary fibrosis. By detailing the IGF2BP1/THBS1/TLR4 pathway, the findings highlight novel targets for fibrosis intervention and inform metabolic and immunologic research strategies.

• 25-Hydroxycholesterol-Driven AMPK Activation in TAM Educatio

  2026-04-18

  Xiao et al. (2024) reveal that 25-hydroxycholesterol accumulates in tumor-associated macrophages (TAMs), activating lysosomal AMPKa via the GPR155-mTORC1 complex and triggering STAT6 phosphorylation. This mechanistic insight highlights CH25H as an immunometabolic checkpoint with implications for reprogramming macrophage function and improving anti-tumor immunity.

• RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy Ass

  2026-04-17

  RapaLink-1, a third-generation mTOR inhibitor, is redefining embryonic dormancy and oncogenic pathway research with its bivalent mechanism and unparalleled potency. Leveraged in both cancer and developmental biology, it offers reproducible, high-throughput workflow enhancements for resistant mTOR signaling models.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-04-16

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for reliable, visually distinct molecular weight standards in SDS-PAGE and Western blot workflows, especially where phosphoprotein compatibility and fluorescent imaging are required. Researchers should select this marker for protocols demanding EDTA-free reagents and broad protein size range, while recognizing that it is not intended for direct protein quantification or as a substitute for unstained standards in precise migration analysis.

• Modeling HSV-1 Latency Using hiPSC-Derived Human Sensory Neu

  2026-04-15

  This study establishes a robust protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, enabling precise modeling of herpes simplex virus 1 (HSV-1) latent infection and reactivation in a scalable human cell system. The platform overcomes barriers in studying neuron-intrinsic mechanisms of HSV-1 latency, providing a significant advancement over animal models for virology and neurobiology research.

15574 records 1/1039 page Next 12345 下5页 Last page